Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; Count What Counts Grant Program Will Provide Pilot Study to Selected Cell and Gene Therapy Researcher PALO ALTO, Calif. -- Countable Labs, the developer of Countable PCR, the leading [...]

SAN DIEGO -- MileCell Biotechnology ("MileCell") today announced the launch of its newly redesigned website www.milecell-bio.com, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also announced the appointments of Nianwei Lin, PhD, Chief Executive Officer and Wayne Vaz, Chief Commercial Officer. The new website was developed to improve usability, streamline product [...]

CAMBRIDGE, UK – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines. Built [...]

Aptco Group announces the acquisition of BlueScientific, a leading UK-based distributor of advanced scientific instrumentation. The acquisition expands Aptco Group’s footprint across Northern Europe and strengthens application and service capabilities for laboratories and R&D organisations. BlueScientific serves customers across the UK, Ireland, the Netherlands and the Nordics. The company’s deep application expertise complements Aptco Group’s portfolio [...]

Genovis AB and MGI Tech Co., Ltd. today announce a strengthened collaboration to advance RNA sequencing solutions. The companies have expanded their commercial agreement to integrate Genovis’ SEQURNA reagents with MGI Tech’s high-performance sequencing platforms, enabling researchers to benefit from enhanced RNA preservation and improved sequencing performance. The partnership marks an important step for both [...]

TOKYO -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discovery and development. As essential tools for innovative drug R&D, functional cell lines need clear, accessible usage authorization to keep projects [...]

DÜSSELDORF, Germany -- LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will integrate our ALiCE® platform with Twist’s DNA manufacturing and automation capabilities to accelerate the design–build–test cycle for protein expression services—delivering experimental results back to customers’ and partners’ AI [...]

LNI Swissgas is pleased to announce its acquisition by Velaris, a platform of leading laboratory automation and analytical technology brands backed by Battery Ventures. This milestone marks an exciting new chapter for LNI Swissgas and supports the company’s long-term strategy for international growth, innovation and expanded customer support capabilities. For more than 30 years, LNI [...]

Toronto companies partner to provide an integrated platform that runs the complete clinical genetics workflow, from patient intake to diagnostic report, entirely on Canadian infrastructure. TORONTO, Ontario — DNAstack and PhenoTips today announced an integrated platform that runs clinical genetics workflows, from patient intake and phenotyping to genomic interpretation and diagnostic report, entirely on Canadian infrastructure. At a time [...]

Licensed purification methods address a key challenge in producing high‑purity, 100+nt RNA constructs used in CRISPR and functional genomics Boulder, CO – Cirena Inc. licensed a validated long RNA purification technology from Agilent Technologies, Inc. as it looks to expand access to high purity RNA constructs used in genome editing and functional genomics research. The [...]